Click here to view this message in your Web browser
   
 

January Business
As we approach the peak season, we want to thank our partners for trusting Tokio Marine HCC – Stop Loss Group (TMHCC) with your clients’ coverage needs. If you need immediate assistance, please reach out to your regional marketing representatives, or visit our website where you will find many resources to answer your questions.


Read more...

ACH Claims and Commissions Payment Processing
Tokio Marine HCC – Stop Loss Group (TMHCC) has a new and improved Automated Clearing House (ACH) payment process for claim reimbursements and commission payments. This new process allows us to provide enhanced customer service and faster turnaround times.


Read more...

2021 Annual Market Report
This year’s report reflects the significant changes we’ve seen in the self-insurance industry throughout the COVID-19 pandemic. From never-before-seen claims to new diseases, the past year has truly been unprecedented. You will also find data on the increasing number of life-saving transplants and million-dollar claims. We have seen delayed FDA approvals of cell and gene therapies due in large part to the pandemic, but we expect to see an increased pipeline of these treatments in the next 12-24 months.


Read more...

Emerging Therapy Solutions® (ETS) Announces Launch of New “Programs of Experience” for CAR-T Designation
For those facing the need for treatment that could include bone marrow transplant or chimeric antigen receptor (CAR) T-cell therapy, the decisions for where and how to be treated are critical. Emerging Therapy Solutions has addressed this need through the creation of ETS Programs of Experience for CAR-T – a new designation that identifies providers that excel at bone marrow transplants and have experience in administering CAR-T therapies.


Read more...

 

 

Organ Transplant Frequently Asked Questions
As you lock in your January accounts, remember to add Tokio Marine HCC – Stop Loss Group’s organ and tissue transplant coverage to your clients’ suite of benefits. We know you may have questions, so we have you covered.


Read more...

 

 

Cell and Gene Therapy Web Page Announcement
Tokio Marine HCC – Stop Loss Group (TMHCC) is pleased to announce the launch of our new Cell & Gene Therapy website. TMHCC has partnered with Emerging Therapy Solutions® (ETS) for best in class service to positively impact the plan and patient.


Read more...

 

 

For producer use only. Not for public distribution.
Copyright 2021, Tokio Marine HCC. Tokio Marine HCC is a member of the Tokio Marine Group of Companies.

Tokio Marine HCC - Stop Loss Group | Corporate Headquarters | 225 TownPark Drive NW, Suite 350 | Kennesaw, GA 30144

Tokio Marine HCC - Stop Loss Group respects your privacy. We do not rent, sell or exchange email addresses. Please see our Privacy Policy for more information. If you do not wish to receive any emails concerning Tokio Marine HCC - Stop Loss Group's policies, changes and events, please click below to unsubscribe.


Click here to unsubscribe to all emails from TMHCC.

 

TMHCC-E2096 092321